Impact on survival outcomes of poorly controlled hypertension after initiation of abiraterone/enzalutamide in patients with metastatic Castration-Resistant Prostate Cancer (mCRPC)

European Urology Open Science(2021)

Cited 0|Views3
No score
Key words
prostate cancer,hypertension,abiraterone/enzalutamide,castration-resistant
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined